SCHEMBL278606

SCHEMBL278606

CNCN(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13589014 0.75
SCHEMBL25572094 0.72
SCHEMBL765210 0.70
SCHEMBL18245436 0.70 PRMT3 (0.39)
SCHEMBL22996398 0.69
SCHEMBL48539 0.69
SCHEMBL19272159 0.69
SCHEMBL14125339 0.69
SCHEMBL25590398 0.69
SCHEMBL20143382 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976339-B1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME (US) 2018-06-27 EP claimed
US-9957264-B2 Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2018-05-01 US claimed
CN-105189498-B Geminally substituted cyanoethylpyrazolopyridinones as JANUS kinase inhibitors 默沙东公司 2017-06-27 CN claimed
US-20160272632-A1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-09-22 US claimed
EP-2976339-A1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-01-27 EP claimed
CN-105189498-A Geminally substituted cyanoethylpyrazolopyridinones as JANUS kinase inhibitors MERCK SHARP & DOHME 2015-12-23 CN claimed
WO-2014146491-A1 GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-09-25 WO claimed
US-4788248-A Thermoplastic resins and polyamides compatibilized with polyamide-polyarylate block copolymers GENERAL ELECTRIC COMPANY (US) 1988-11-29 US claimed
WO-2024130570-A1 LIGHT EMITTING DIODE AND DISPLAY APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2024-06-27 WO disclosed
US-11912650-B2 Bakuchiol derivatives, pharmaceutically acceptable salts thereof, and preparation method and use of the same JIANGXI SHIMEI PHARMACEUTICAL CO., LTD (CN) 2024-02-27 US disclosed
WO-2024011307-A1 PYRAZOLO[3,4-D]PYRIMIDIN-6-YL-SULFONAMIDE DERIVATIVES FOR THE INHIBITION OF SGK-1 AND TREATMENT OF CANCER THRYV THERAPEUTICS INC. (CA) 2024-01-18 WO disclosed
EP-4151687-B1 METALLIZED ARTICLE AND ASSOCIATED POLY(PHENYLENE ETHER) COMPOSITION AND INJECTION-MOLDED ARTICLE SHPP GLOBAL TECH BV (NL) 2023-11-29 EP disclosed
US-20230338906-A1 SEPARATION MEMBRANE NITTO DENKO CORPORATION (JP) 2023-10-26 US disclosed
WO-2023108291-A9 APELINERGIC MACROCYCLES AND USES THEREOF SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) 2023-09-28 WO disclosed
US-20050038037-A1 Platelet adenosine diphosphate receptor antagonists SCHERING AKTIENGESELLSCHAFT (DE) 2005-02-17 US disclosed
EP-1412349-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS Schering Aktiengesellschaft (DE) 2004-04-28 EP disclosed
US-20030060474-A1 Platelet adenosine diphosphate receptor antagonists SCHERING AKTIENGESELLSCHAFT (DE) 2003-03-27 US disclosed
WO-2002098856-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2002-12-12 WO disclosed
US-5449737-A Urethane modified epoxy resin compositions CIBA-GEIGY CORPORATION (US) 1995-09-12 US disclosed
US-4055413-A SULFIDES THE PROCTER & GAMBLE COMPANY (US) 1977-10-25 US disclosed